Dana Farber/Brigham and Women's Cancer Center — Boston, Massachusetts

Dana Farber/Brigham and Women's Cancer Center is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Dana Farber/Brigham and Women's Cancer Center has participated in 1 clinical trials.

Therapeutic areas: Advanced and/or Metastatic Solid Organ Cancer.

Sponsors: Vascular Biogenics Ltd. operating as VBL Therapeutics.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana Farber/Brigham and Women's Cancer Center?

Dana Farber/Brigham and Women's Cancer Center has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana Farber/Brigham and Women's Cancer Center conducted?

Dana Farber/Brigham and Women's Cancer Center has 1 clinical trials on record. Their work covers Advanced and/or Metastatic Solid Organ Cancer.

Is Dana Farber/Brigham and Women's Cancer Center accredited by Crixeo Health?

Dana Farber/Brigham and Women's Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana Farber/Brigham and Women's Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.